Is Kewaunee Scientific Corp. overvalued or undervalued?

As of 30 June 2025, Kewaunee Scientific Corp. has moved from expensive to attractive, indicating a shift in its valuation perspective. The company is currently considered undervalued, supported by a P/E ratio of 6, a Price to Book Value of 1.85, and an EV to EBITDA ratio of 7.61. In comparison, Pro-Dex, Inc. has a higher P/E of 14.77 and an EV to EBITDA of 10.46, while Lucid Diagnostics, Inc. shows a negative P/E, highlighting Kewaunee's relative attractiveness in its sector.
Despite a challenging year-to-date return of -26.30% compared to the S&P 500's 12.22%, Kewaunee has shown strong long-term performance with a 3-year return of 146.49% versus the S&P 500's 70.41%. This suggests that while recent performance has been weak, the company's long-term growth potential remains compelling.